Pictet Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.6M | Buy |
682,499
+2,751
| +0.4% | +$74.8K | 0.02% | 526 |
|
|
2025
Q1 | $20.8M | Sell |
679,748
-1,086,650
| -62% | -$33.2M | 0.02% | 485 |
|
|
2024
Q4 | $73.4M | Buy |
1,766,398
+1,113,455
| +171% | +$46.3M | 0.08% | 245 |
|
|
2024
Q3 | $43.1M | Sell |
652,943
-461,219
| -41% | -$30.4M | 0.05% | 321 |
|
|
2024
Q2 | $132M | Sell |
1,114,162
-1,507,475
| -58% | -$179M | 0.15% | 162 |
|
|
2024
Q1 | $282M | Buy |
2,621,637
+824,187
| +46% | +$88.5M | 0.31% | 84 |
|
|
2023
Q4 | $179M | Buy |
1,797,450
+407,441
| +29% | +$40.5M | 0.2% | 132 |
|
|
2023
Q3 | $144M | Buy |
+1,390,009
| New | +$144M | 0.18% | 152 |
|